How much is a share of emhtf worth?
One share of EMHTF stock can currently be purchased for approximately $0.05. How many employees does Emerald Health Therapeutics have? Emerald Health Therapeutics employs 110 workers across the globe.
Is emerald health Therapeutics (emhtf) stock going down?
Since then, EMHTF stock has decreased by 69.0% and is now trading at $0.0450. View which stocks have been most impacted by COVID-19. Are investors shorting Emerald Health Therapeutics? Emerald Health Therapeutics saw a decrease in short interest in the month of December.
Will Emerald health Therapeutics (emhtf) underperform the S&P 500?
Vote “Underperform” if you believe EMHTF will underperform the S&P 500 over the long term. You may vote once every thirty days. Emerald Health Therapeutics does not currently pay a dividend.
HYTN Innovations Awarded Approval for the Sale of Cannabis to Provincially and Territorially Authorized Retailers
Emerald Health Therapeutics Sells Patents to FlowerPod
KELOWNA, British Columbia, Feb. 22, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc.
Emerald Health Therapeutics Reports 2021 AGM Results
Vancouver, British Columbia-- (Newsfile Corp. - January 11, 2022) - Emerald Health Therapeutics, Inc.
How has Emerald Health Therapeutics' stock been impacted by COVID-19 (Coronavirus)?
Vancouver, British Columbia-- (Newsfile Corp. - December 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has announced the results of voting at its annual general meeting held December 30, 2021.
Are investors shorting Emerald Health Therapeutics?
Emerald Health Therapeutics' stock was trading at $0.1450 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, EMHTF stock has decreased by 71.7% and is now trading at $0.0411. View which stocks have been most impacted by COVID-19.
Who are some of Emerald Health Therapeutics' key competitors?
Emerald Health Therapeutics saw a decline in short interest in January. As of January 15th, there was short interest totaling 13,400 shares, a decline of 82.3% from the December 31st total of 75,500 shares.
What is Emerald Health Therapeutics' stock symbol?
Some companies that are related to Emerald Health Therapeutics include 18564 (NBL.L) (NBL), Cooper Energy (COPJF), Crown Point Energy (CWVLF), Freehold Royalties (FRHLF), GASFRAC Energy Services (GSFVF), Gulf Coast Ultra Deep Royalty Trust (GULTU), Headwater Exploration (CDDRF), International Petroleum (IPCFF), Japan Petroleum Exploration (JPTXF), Leucrotta Exploration (LCRTF), Manitok Energy (MKRYF), Petro Matad (PRTDF), PetroShale (PSHIF), Pond Technologies (PNDHF) and Santos (STOSF). View all of EMHTF's competitors..
How do I buy shares of Emerald Health Therapeutics?
Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."
What is Emerald Health Therapeutics' stock price today?
Shares of EMHTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is Emerald Health Therapeutics' official website?
One share of EMHTF stock can currently be purchased for approximately $0.04.
What is Emerald Health Therapeutics?
The official website for Emerald Health Therapeutics is www.emerald.care.
How long are futures trading delayed?
Emerald Health Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the production and sale of cannabis products. Its products include dried cannabis and cannabis oil, pants and seeds. The company was founded on Jul 31, 2007 and is headquartered...
How to calculate P/E?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
How to calculate restricted stock?
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
